Publications by authors named "Qingya Cui"

Claim this Profile
H
HSQC-guided discovery and structural optimization of antiadipogenic indole diterpenoids from endophytic fungus Penicillium janthinellum H-6.
Lei Li, Xin-Ying Zhu, Jun-Yu Zhu, Qing-Ya Cui, Yu-Wei Lin

Eur J Med Chem· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective Management of Carbapenem-Resistant Enterobacterales Bloodstream Infection with Organ Dissemination in Prolonged Severe Agranulocytosis Patients with Hematological Malignancy Through Combination Therapies Including Eravacycline.
Yuyuan Lv, Xin Zhang, Qingya Cui, Mengyun Li, Lian Bai

Infect Dis Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-6 knockdown anti-CD19 CAR-T cells (ssCART-19) for patients with relapsed or refractory acute lymphoblastic leukemia: phase 1 trial.
Sheng-Li Xue, Mei-Jing Liu, Chong-Sheng Qian, Su-Ning Chen, Hui-Ying Qiu, Qing-Ya Cui

Blood Cancer J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tandem CD19/CD22 CAR T-Cell Therapy as First-Line Treatment for Adult Patients With High-Risk Philadelphia Chromosome Negative B-Cell Acute Lymphoblastic Leukemia.
Mengyun Li, Qingya Cui, Xuekai Li, Wei Cui, Xiaoqian Chen

Am J Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD19 CAR-T in relapsed t(8;21) AML: a single-center prospective phase II clinical trial.
Jia Yin, Qing-Ya Cui, Hai-Ping Dai, Chang-Ju Qu, Zheng Li, Wei Cui

J Hematol Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sclerotiorin-Type Azaphilones Isolated from a Marine-Derived Fungus P1B.
Qing-Ren Lu, Lei Li, Qing-Ya Cui, Qiong Liao, Nirmal Malik

J Nat Prod· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab potentially improves clinical outcomes of CAR-T therapy for r/r B-ALL via sensitizing leukemia cells to CAR-T-mediated cytotoxicity and reducing CAR-T exhaustion.
Yangzi Li, Qingya Cui, Sining Liu, Lingling Liu, Megyn Li, Wei Cui

Cell Oncol (Dordr)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decitabine consolidation after CD19/CD22 CAR-T therapy as a novel maintenance treatment significantly improves survival outcomes in relapsed/refractory B-ALL patients.
Tingting Li, Qingya Cui, Sining Liu, Zheng Li, Wei Cui

Leuk Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Construction and Validation of an Assistant Decision-Making Model for Platelet Transfusion Refractoriness in Patients with Acute Myeloid Leukemia.
Ruixue Ma, Yunju Ma, Qingya Cui, Depei Wu, Xiaowen Tang

Clin Appl Thromb Hemost· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Familial Acute Promyelocytic Leukemia: A Case Report and Review of the Literature.
Mingqi Yang, Lian Bai, Yunju Ma, Xuanqi Cao, Qingya Cui

Onco Targets Ther· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Cell Spatial Transcriptomics Unveils Platelet-Fueled Cycling Macrophages for Kidney Fibrosis.
Jun Liu, Bo Zheng, Qingya Cui, Yu Zhu, Likai Chu

Adv Sci (Weinh)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chidamide combined with a modified Bu-Cy conditioning regimen improves survival in patients with T-cell acute lymphoblastic leukemia/lymphoma undergoing allogeneic hematopoietic stem cell transplantation.
Xuanqi Cao, Zheng Li, Yanming Zhang, Qingya Cui, Haiping Dai, Wei Cui

Ann Hematol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment of a B/T MPAL patient by chemo-free treatment with venetoclax, azacitidine, and blinatumomab.
Shaoyu Liu, Qingya Cui, Mengyun Li, Zheng Li, Sifan Chen

Ann Hematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of tandem CD19/CD22 CAR T-Cells in r/r B-ALL patients with high-risk features.
Wei Cui, Xin-Yue Zhang, Zheng Li, Hai-Ping Dai, Jia Yin, Qing-Ya Cui

Am J Hematol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decitabine in combination with fludarabine and cyclophosphamide as a lymphodepletion regimen followed by CD19/CD22 bispecific targeted CAR T-cell therapy significantly improves survival in relapsed/refractory B-ALL patients.
Yunju Ma, Haiping Dai, Qingya Cui, Sining Liu, Liqing Kang, Wei Cui

Exp Hematol Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy?
Sining Liu, Xinyue Zhang, Haiping Dai, Wei Cui, Jia Yin, Qingya Cui

Blood Cancer J· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: CD38-directed CAR-T cell therapy: A novel immunotherapy targeting CD38- positive blasts overcomes TKI and chemotherapy resistance of myeloid chronic myeloid leukemia in blastic phase.
Qingya Cui, Peiqi Liang, Haiping Dai, Wei Cui, Mengjie Cai

Front Immunol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Rare persistent complete donor chimerism and GVHD following micro-transplantation from HLA haplotype homozygous donors.
Lingling Liu, Qingya Cui, Mengyun Li, Zheng Li, Sifan Chen

Front Immunol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD7-directed CAR T-cell therapy: a potential immunotherapy strategy for relapsed/refractory acute myeloid leukemia.
Xuanqi Cao, Haiping Dai, Qingya Cui, Zheng Li, Wenhong Shen

Exp Hematol Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of ferroptosis promotes megakaryocyte differentiation and platelet production.
Baoquan Song, Wenjing Miao, Qingya Cui, Bingyu Shi, Jian Zhang

J Cell Mol Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of the Predictive Models for the Treatment Response of Refractory/Relapsed B-Cell ALL Patients Receiving CAR-T Therapy.
Jingxian Gu, Sining Liu, Wei Cui, Haiping Dai, Qingya Cui

Front Immunol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: A Case of Acute T Lymphoblastic Leukemia With Mixed Infection of Lethal Invasive Mucormycosis and Multi-Drug Resistant Bacteria.
Qingya Cui, Haiping Dai, Depei Wu, Jun He, Yang Xu

Front Med (Lausanne)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haploidentical CD7 CAR T-cells induced remission in a patient with TP53 mutated relapsed and refractory early T-cell precursor lymphoblastic leukemia/lymphoma.
Hai-Ping Dai, Wei Cui, Qing-Ya Cui, Wen-Juan Zhu, Hui-Min Meng

Biomark Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful application of PD-1 knockdown CLL-1 CAR-T therapy in two AML patients with post-transplant relapse and failure of anti-CD38 CAR-T cell treatment.
Yun-Ju Ma, Hai-Ping Dai, Qing-Ya Cui, Wei Cui, Wen-Juan Zhu

Am J Cancer Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The Effect of Immunized Platelet Transfusion Refractoriness on Allo-HSCT Patients with Malignant Hematological Diseases].
Yuan-Ling Zuo, Ju-Ping Zhai, Yong Li, Min Jiang, Qing-Ya Cui

Zhongguo Shi Yan Xue Ye Xue Za Zhi· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis